These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

259 related items for PubMed ID: 14624375

  • 1. Hepatitis C virus (HCV) and human immunodeficiency virus (HIV) dynamics during HCV treatment in HCV/HIV coinfection.
    Torriani FJ, Ribeiro RM, Gilbert TL, Schrenk UM, Clauson M, Pacheco DM, Perelson AS.
    J Infect Dis; 2003 Nov 15; 188(10):1498-507. PubMed ID: 14624375
    [Abstract] [Full Text] [Related]

  • 2. Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b.
    Vispo E, Barreiro P, Rodriguez-Nóvoa S, Morello J, Labarga P, Martín-Carbonero L, Maida I, García-Gascó P, Soriano V.
    Antivir Ther; 2008 Nov 15; 13(4):511-7. PubMed ID: 18672529
    [Abstract] [Full Text] [Related]

  • 3. Response to pegylated interferon plus ribavirin among HIV/hepatitis C virus-coinfected patients with compensated liver cirrhosis.
    Mira JA, García-Rey S, Rivero A, de los Santos-Gil I, López-Cortés LF, Girón-González JA, Téllez F, Márquez M, Merino D, Ríos-Villegas MJ, Macías J, Rivero-Juárez A, Pineda JA.
    Clin Infect Dis; 2012 Dec 15; 55(12):1719-26. PubMed ID: 22955435
    [Abstract] [Full Text] [Related]

  • 4. Critical role of ribavirin for the achievement of early virological response to HCV therapy in HCV/HIV-coinfected patients.
    Ramos B, Núñez M, Rendón A, Berdún MA, Losada E, Santos I, Echevarría S, Ocampo A, Miralles C, Arazo P, Barreiro P, Romero M, Labarga P, Guardiola JM, Garcia-Samaniego J, Soriano V.
    J Viral Hepat; 2007 Jun 15; 14(6):387-91. PubMed ID: 17501758
    [Abstract] [Full Text] [Related]

  • 5. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment.
    Massanella M, Tural C, Papagno L, Garcia E, Jou A, Bofill M, Autran B, Clotet B, Blanco J.
    Antivir Ther; 2010 Jun 15; 15(3):333-42. PubMed ID: 20516553
    [Abstract] [Full Text] [Related]

  • 6. Effect of an induction period of pegylated interferon-α2a and ribavirin on early virological response in HIV-HCV-coinfected patients: results from the CORAL-2 study.
    Tural C, Solà R, Alvarez NP, Moltó J, Sánchez M, Zamora AM, Ornelas A, Laguno M, González J, von Wichmann MÁ, Téllez MJ, Paredes R, Clotet B, CORAL-2 study group.
    Antivir Ther; 2011 Jun 15; 16(6):833-41. PubMed ID: 21900715
    [Abstract] [Full Text] [Related]

  • 7. Rapid virological response at week 4 predicts response to pegylated interferon plus ribavirin among HIV/HCV-coinfected patients.
    Mira JA, Valera-Bestard B, Arizcorreta-Yarza A, González-Serrano M, Torre-Cisneros J, Santos I, Vergara S, Gutiérrez-Valencia A, Girón-González JA, Macías J, López-Cortés LF, Pineda JA.
    Antivir Ther; 2007 Jun 15; 12(4):523-9. PubMed ID: 17668561
    [Abstract] [Full Text] [Related]

  • 8. HCV clearance from saliva of HIV-HCV-coinfected patients on treatment with interferon plus ribavirin.
    Feijoo J, Eirea M, Limeres J, Abeleira M, Ramos I, Ocampo A, Diz P.
    Oral Dis; 2014 Apr 15; 20(3):313-8. PubMed ID: 23607445
    [Abstract] [Full Text] [Related]

  • 9. Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients.
    Pineda JA, Mira JA, Gil Ide L, Valera-Bestard B, Rivero A, Merino D, Girón-González JA, Ríos-Villegas MJ, González-Serrano M, Collado A, García-García JA, Carrillo-Gómez R, López-Cortés LF, Gómez-Mateos J.
    J Antimicrob Chemother; 2007 Dec 15; 60(6):1347-54. PubMed ID: 17938129
    [Abstract] [Full Text] [Related]

  • 10. Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients.
    Neumann A, Polis M, Rozenberg L, Jackson J, Reitano K, McLaughlin M, Koratich C, Dewar R, Masur H, Haagmans B, Kottilil S.
    AIDS; 2007 Sep 12; 21(14):1855-65. PubMed ID: 17721093
    [Abstract] [Full Text] [Related]

  • 11. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ, Horn PS, Rouster SD, Stanford S, Eyster ME, Sherman KE, Multicenter Hemophilia Cohort HCV Study Group.
    Hepatology; 2006 Nov 12; 44(5):1146-57. PubMed ID: 17058240
    [Abstract] [Full Text] [Related]

  • 12. Comparison of serum hepatitis C virus (HCV) RNA and core antigen levels in patients coinfected with human immunodeficiency virus and HCV and treated with interferon plus ribavirin.
    Pivert A, Payan C, Morand P, Fafi-Kremer S, Deshayes J, Carrat F, Pol S, Cacoub P, Perronne C, Lunel F.
    J Clin Microbiol; 2006 Feb 12; 44(2):417-22. PubMed ID: 16455894
    [Abstract] [Full Text] [Related]

  • 13. Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients.
    Sherman KE, Shire NJ, Rouster SD, Peters MG, James Koziel M, Chung RT, Horn PS.
    Gastroenterology; 2005 Feb 12; 128(2):313-27. PubMed ID: 15685543
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of peg-IFN alfa-2a with ribavirin for the treatment of HCV/HIV coinfected patients who failed previous IFN based therapy.
    Rodríguez-Torres M, Rodríguez-Orengo JF, Ríos-Bedoya CF, Fernández-Carbia A, González-Lassalle E, Salgado-Mercado R, Marxuach-Cuétara AM.
    J Clin Virol; 2007 Jan 12; 38(1):32-8. PubMed ID: 17064957
    [Abstract] [Full Text] [Related]

  • 15. Open, randomized, multicentre italian trial on PEG-IFN plus ribavirin versus PEG-IFN monotherapy for chronic hepatitis C in HIV-coinfected patients on HAART.
    Cargnel A, Angeli E, Mainini A, Gubertini G, Giorgi R, Schiavini M, Duca P, Italian Co-infection Study (ICOS) Group.
    Antivir Ther; 2005 Jan 12; 10(2):309-17. PubMed ID: 15865225
    [Abstract] [Full Text] [Related]

  • 16. Hepatitis C virus-RNA clearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin.
    Soriano V, Núñez M, Camino N, Maida I, Barreiro P, Romero M, Martin-Carbonero L, Garcia-Samaniego J, González-Lahoz J.
    Antivir Ther; 2004 Aug 12; 9(4):505-9. PubMed ID: 15456081
    [Abstract] [Full Text] [Related]

  • 17. Results of a study of prolonging treatment with pegylated interferon-alpha2a plus ribavirin in HIV/HCV-coinfected patients with no early virological response.
    Fuster D, Planas R, Gonzalez J, Force L, Cervantes M, Vilaró J, Roget M, García I, Pedrol E, Tor J, Ballesteros AL, Salas A, Sirera G, Videla S, Clotet B, Tural C.
    Antivir Ther; 2006 Aug 12; 11(4):473-82. PubMed ID: 16856621
    [Abstract] [Full Text] [Related]

  • 18. Viral kinetics and early prediction of nonresponse to peg-IFN-alpha-2b plus ribavirin in HCV genotypes 1/4 according to HIV serostatus.
    Moreno A, Bárcena R, García-Garzón S, Moreno L, Quereda C, Muriel A, Zamora J, Mateos ML, Pérez-Elías MJ, Antela A, Diz S, Moreno A, Moreno S.
    J Viral Hepat; 2006 Jul 12; 13(7):466-73. PubMed ID: 16792540
    [Abstract] [Full Text] [Related]

  • 19. The association of cytopenias and weight loss with hepatitis C virus virologic response in HIV/HCV-coinfected patients treated with PEG-IFN and RBV.
    Slim J, Mildvan D, Han J, Korner E.
    J Int Assoc Provid AIDS Care; 2013 Jul 12; 12(5):354-62. PubMed ID: 23873217
    [Abstract] [Full Text] [Related]

  • 20. Efficacy of and risk of bleeding during pegylated interferon plus ribavirin treatment in HIV/HCV-coinfected patients with pretreatment thrombocytopenia.
    Mira JA, Neukam K, López-Cortés LF, Rivero-Juárez A, Téllez F, Girón-González JA, de los Santos-Gil I, Ojeda-Burgos G, Merino D, Ríos-Villegas MJ, Collado A, Torres-Cornejo A, Macías J, Rivero A, Pérez-Pérez M, Pineda JA, Grupo Andaluz para el Estudio de las Hepatitis Víricas (HEPAVIR) de la Sociedad Andaluza de Enfermedades Infecciosas (SAEI), Red de Investigación en SIDA (RIS-HEP07).
    Eur J Clin Microbiol Infect Dis; 2015 Sep 12; 34(9):1879-84. PubMed ID: 26115631
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.